FDA Investigator Patrice S Hall

Patrice S Hall has conducted inspections on 41 sites in 5 countries as of 29 Nov 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
41
Last Inspection Date:
29 Nov 2016
Investigator Role:
FDA Investigator
Redica ID:
100009124
Countries of Inspections:
Switzerland, United States of America, India, Italy, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Patrice S Hall:
Adam C Hipko, Ademola O Daramola, Adrian Rodriguez, Akbar J Zaidi, Alcee M Tavarez, Amanda J White, Andrea A Branche, Anh M Lac, Aqualia L Nelson, Arie R Dyk, Ashley N Williams, Barbara Jwilimczyk Macri, Bobbi J Miller, Bonita S Chester, Brackens Harris, Brandi E Williams, Brandon K Barbee, Camerson E Moore, Camille D Brown, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles B Steinmiller, Charles D Brown, Christine L Williams, Christopher D Leach, Christopher D Rush, Christopher J Hurst, Colleen F Hoyt, Dallas E Gilbreath Jr, Damaris Y Hernandez, Daniel J Lahar, Daniel J Roberts, Darla J Christopher, David J Leray, David M Beltran, Decarlos A Gomez, Deniza Karacic, Dennis Cantellops Paite, Douglas C Kovacs, Dr. Jason R Caballero, Ed Gonzalez Vazquez, Elisa M Fleming, Elmina E Akwo, Elvia J Cervantes, Erika V Butler, Ernest Serna, III, Farhana Khan, Feiyan Jin, Fernando C Martinez, Glasgow Glasgow, H Ljamilla Selby, Hala L Selby, Iris C Macinnes, J Elkins, Jacey Roy, Jacob S Foster, Jamirya S Weatherly, Janice M Hickok, Jeffrey D Meng, Jeffrey R Wooley, Jenny Agila Sefen, Jessica M Simpson, PhD, Jodi M Gatica, Joel D Martinez, Johann M Fitch, John T Chapman, Jose Martinez, Jr, Juan D Lopez, Jude C Dikes, Katherine Szestypalow, Kathleen Chmura Shaffer, Kelvin R Wright, L Grant, Lance Mde Souza, MBA, Latorie S Jones, Lauren E Skokan, Liming Zhang, Linda Linh N Adams, Lisa M Puttonen, Lisa R Jennings, Lisa R Whitt, Liza L Quiles, Lori G Cantin, Lorie S Hannappel, Lucas B Leake, Margaret M Annes, Mario Seminara, Marla A Cassidy, Massoud Motamed, Matthew B Casale, Matthew R Maddox, Michael A Charles, Michael E Maselli, Michael L Casner, Michael R Goga, Mra Davism, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nimmy Mathews, Parul M Patel, Patrick L Wisor, Patty P Kaewussdangkul, Pauline N Logan, Philip M Steele, PhD, Pratik S Upadhyay, DDC, Rebecca Co Bryan, Rebecca Rodriguez, Regina D Hunt, Rene R Ramirez, Rhonda L Dash, Rian L Pope, Richard L Rutherford, Richard T Riggie, Robert T Lorenz, Ronan F King, Ronda Rloyd Jones, Roy Baby, Russell J Glapion, Sandy J Ziegler, Scott T Ballard, Sha'tina R Alridge, Shanna N Purdy, Shannon A Lowe, Sharmista Chatterjee, Shawn E Larson, Sherrie L Krolczyk, Sneha S Patel, Staci G Mcallister, Stephen D Brown, Stephen D Eich, Stephen L Beekman, Steven D Kehoe, Tamera H Hunt, Terri E Gibson, Timothy B Webb, Tonya R Johnson, Travis S Brown, Trina K Vick, Tsedenia Woldehanna, Valerie L Whipp, Xiaohui Shen, Yaw O Osei, Young M Yoon, Yumi J Hiramine, Yvins Dezan

Patrice S Hall's Documents

Publish Date Document Type Title
December, 2014 FDA 483 Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop - Form 483, 2014-12-12
August, 2016 FDA 483 United Laboratories Manufacturing, LLC - Form 483, 2016-08-26
May, 2015 FDA 483 Home Intensive Care Pharmacy, Inc. - Form 483, 2015-05-05
September, 2015 FDA 483 INCELL Corporation LLC - Form 483, 2015-09-01
August, 2016 FDA 483 Phillips Co. - Form 483, 2016-08-11
June, 2014 FDA 483 Dhaliwal Laboratories, LLC - Form 483, 2014-06-20
October, 2015 FDA 483 Downing Labs, LLC - Form 483, 2015-10-09
June, 2014 EIR Dhaliwal Laboratories, LLC - EIR, 2014-06-20
October, 2016 FDA 483 Response Guardian Pharmacy Services - Form 483R, 2016-11-07
October, 2016 FDA 483 Guardian Pharmacy Services - Form 483, 2016-10-21
May, 2016 FDA 483 SOFIE Co. dba SOFIE - Form 483, 2016-05-27
August, 2016 EIR United Laboratories Manufacturing, LLC - EIR, 2016-08-26
January, 2015 EIR QuVa Pharma, Inc. - EIR, 2015-01-23
January, 2015 FDA 483 QuVa Pharma, Inc. - Form 483, 2015-01-23

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more